文献速递糖尿病

当代2型糖尿病合并动脉粥样硬化性心血管疾病患者队列的死因分析:来自TECOS试验的启示

Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial.
PubMed 文献 · Diabetes Care · 2017-10-06

基于TECOS试验(n=14,671)中2型糖尿病合并动脉粥样硬化性心血管疾病患者的数据,中位随访3年,共裁定1,084例死亡:心血管死亡530例(1.2/100患者年,占49%),非心血管死亡338例(0.77/100患者年,占31%),不明原因死亡216例(0.49/100患者年,占20%)。心血管死亡中最常见为猝死(n=145,占心血管死亡的27%),其次为急性心肌梗死/卒中(n=113,占21%)和心力衰竭(n=63,占12%);非心血管死亡中最常见为恶性肿瘤(n=154,占非心血管死亡的46%)。无基线心力衰竭病史的患者特定心血管死亡亚类风险较低。

要点

  • 心血管死亡占49%,其中猝死最常见(占心血管死亡的27%)。
  • 非心血管死亡占31%,恶性肿瘤最常见(占非心血管死亡的46%)。
  • 无基线心力衰竭病史者猝死、心肌梗死/卒中死亡及心力衰竭死亡风险较低。

核心结论

  • 在当代2型糖尿病合并动脉粥样硬化性心血管疾病患者队列中,猝死是心血管死亡中最常见的亚类。
  • 预防心力衰竭可能有助于降低特定心血管死亡亚类的风险。

研究设计与样本

  • TECOS试验(n=14,671)是一项在2型糖尿病合并动脉粥样硬化性心血管疾病患者中,在常规治疗基础上加用西格列汀对比安慰剂的的心血管安全性试验,中位随访3年。
  • 由独立委员会对治疗分组设盲裁定每例死亡原因,采用Cox比例风险模型识别与各结局相关的危险因素。

主要发现

  • 共裁定1,084例死亡:心血管死亡530例(1.2/100患者年,占49%),非心血管死亡338例(0.77/100患者年,占31%),不明原因死亡216例(0.49/100患者年,占20%)。
  • 心血管死亡中最常见为猝死(n=145,占心血管死亡的27%),其次为急性心肌梗死/卒中(n=113,中心肌梗死n=48、卒中n=65,占心血管死亡的21%),心力衰竭死亡(n=63,占心血管死亡的12%)。
  • 非心血管死亡中最常见为恶性肿瘤(n=154,占非心血管死亡的46%)。
  • 无基线心力衰竭病史的患者特定心血管死亡亚类风险较低:猝死(HR 0.4;P=0.0036)、心肌梗死/卒中死亡(HR 0.47;P=0.049)、心力衰竭死亡(HR 0.29;P=0.0057)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We evaluated the specific causes of death and their associated risk factors in a contemporary cohort of patients with type 2 diabetes and atherosclerotic cardiovascular disease (ASCVD). RESEARCH DESIGN AND METHODS: We used data from the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) study (n = 14,671), a cardiovascular (CV) safety trial adding sitagliptin versus placebo to usual care in patients with type 2 diabetes and ASCVD (median follow-up 3 years). An independent committee blinded to treatment assignment adjudicated each cause of death. Cox proportional hazards models were used to identify risk factors associated with each outcome. RESULTS: A total of 1,084 deaths were adjudicated as the following: 530 CV (1.2/100 patient-years [PY], 49% of deaths), 338 non-CV (0.77/100 PY, 31% of deaths), and 216 unknown (0.49/100 PY, 20% of deaths). The most common CV death was sudden death (n = 145, 27% of CV death) followed by acute myocardial infarction (MI)/stroke (n = 113 [MI n = 48, stroke n = 65], 21% of CV death) and heart failure (HF) (n = 63, 12% of CV death). The most common non-CV death was malignancy (n = 154, 46% of non-CV death). The risk of specific CV death subcategories was lower among patients with no baseline history of HF, including sudden death (hazard ratio [HR] 0.4; P = 0.0036), MI/stroke death (HR 0.47; P = 0.049), and HF death (HR 0.29; P = 0.0057). CONCLUSIONS: In this analysis of a contemporary cohort of patients with diabetes and ASCVD, sudden death was the most common subcategory of CV death. HF prevention may represent an avenue to reduce the risk of specific CV death subcategories.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Sharma A, Green JB, Dunning A, et al. Causes of Death in a Contemporary Cohort of Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease: Insights From the TECOS Trial. Diabetes Care. 2017. PMID: 28986504. doi:10.2337/dc17-1091

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。